We are live on
!
Find out more
SPA
Sherbrooke Park Advisers Portfolio holdings
AUM
$38.7M
1-Year Est. Return
5.29%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
(+7.3%)
Cap. Flow
+$5.46M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$1.45M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.42M |
| 3 |
Genpact
G
|
+$1.42M |
| 4 |
C.H. Robinson
CHRW
|
+$1.34M |
| 5 |
OGE Energy
OGE
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.44M |
| 2 |
Mondelez International
MDLZ
|
+$1.42M |
| 3 |
Avnet
AVT
|
+$1.21M |
| 4 |
Marvell Technology
MRVL
|
+$1.04M |
| 5 |
XYZ
Block Inc
XYZ
|
+$987K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 15.35% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 12.99% |
| 5 | Financials | 10.27% |
Similar funds
2C
SIM
ISSM
KCM
EFI
ICM
APM
CI
Sherbrooke Park Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.
Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
- Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
- Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
- Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
- Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
- Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
- Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.
Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.